Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission -confounded by the gut microbiome?

Rupert W. L. Leong; Nadeem O. Kaakoush; Yunki Y. Yau; Valerie C. Wasinger

doi:10.1111/apt.15171

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission -confounded by the gut microbiome?

Rupert W. L. Leong, Nadeem O. Kaakoush, Yunki Y. Yau, Valerie C. Wasinger

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1086-1087
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	49
Issue number	8
DOIs	https://doi.org/10.1111/apt.15171
Publication status	Published - 1 Apr 2019
Externally published	Yes

Access to Document

10.1111/apt.15171

Cite this

@article{9dd19d3c68274e07922482149a0fbaaa,

title = "Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission -confounded by the gut microbiome?",

author = "Leong, {Rupert W. L.} and Kaakoush, {Nadeem O.} and Yau, {Yunki Y.} and Wasinger, {Valerie C.}",

year = "2019",

month = apr,

day = "1",

doi = "10.1111/apt.15171",

language = "English",

volume = "49",

pages = "1086--1087",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell, Wiley",

number = "8",

}

Editorial : metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission -confounded by the gut microbiome? / Leong, Rupert W. L.; Kaakoush, Nadeem O.; Yau, Yunki Y. et al.

In: Alimentary Pharmacology and Therapeutics, Vol. 49, No. 8, 01.04.2019, p. 1086-1087.

Research output: Contribution to journal › Editorial › peer-review

TY - JOUR

T1 - Editorial

T2 - metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission -confounded by the gut microbiome?

AU - Leong, Rupert W. L.

AU - Kaakoush, Nadeem O.

AU - Yau, Yunki Y.

AU - Wasinger, Valerie C.

PY - 2019/4/1

Y1 - 2019/4/1

UR - http://www.scopus.com/inward/record.url?scp=85063945735&partnerID=8YFLogxK

U2 - 10.1111/apt.15171

DO - 10.1111/apt.15171

M3 - Editorial

C2 - 30920041

VL - 49

SP - 1086

EP - 1087

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 8

ER -

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission -confounded by the gut microbiome?

Access to Document

Other files and links

Cite this